Cingal (Hyaluronic Acid)

CINGAL® Hyaluronic Acid Injections for Knee Osteoarthritis

CINGAL® is a single-injection treatment designed to relieve pain and improve joint function in patients with knee osteoarthritis (OA).

It combines a corticosteroid with a high-concentration, cross-linked hyaluronic acid to restore the cushioning and lubricating properties of the knee. This can help reduce pain for up to 6-9 months.

CINGAL® offers a safe, effective, and convenient option for managing knee osteoarthritis and improving quality of life without surgery.

Cingal Hyaluronic Acid Injection
Osteoarthritic Joint Comparison

What is it used for?

Used in knee Osteoarthritis.

Arthritic knees tend to produce lower concentrations of hyaluronic acid which is used to lubricate the knee.

Without HA the knee is less shock absorbing and can be a cause of pain.

If you are not ready for surgery and over-the-counter and prescription pain medications no longer provide pain relief, talk to Dr Ibrahim about hyaluronic acid injections as an option for managing your knee pain.

Frequently Asked Questions

How long does it last for?
  • Typically an injection of HA will last for 6-9 months.
  • A recent study showed that repeated injections every 6 months for 2 years, followed by yearly injections is the best method to administer Cingal.
  • Arthritic knees produce less natural hyaluronic acid, reducing shock absorption and causing pain.
  • CINGAL restores lubrication, improving movement and comfort.
  • Administered as a single injection under ultrasound guidance.
  • Minimal pain; some may require a local anaesthetic.
  • Patients can walk out and drive home afterwards.
  • Pain relief can begin within 48 hours, with most patients noticing improvement within 1-2 weeks.
  • Minor side effects are rare and usually resolve naturally, including temporary injection site pain, swelling, or redness.
  • Not suitable for patients with bleeding disorders, active joint or skin infections, or hypersensitivity to hyaluronic acid.
  • Not recommended for pregnant or lactating women.
  • CINGAL is a private medication and not covered by Medicare.
  • Some private health funds may provide rebates; our clinic can provide supporting letters.

Articles

“Runner’s Trots”: The Real Medical Reason Endurance Athletes Sometimes Lose Bowel Control

What really happens when an elite athlete suddenly loses bowel control mid-race? The recent HYROX incident involving Australian athlete Joanna Wietrzyk put “runner’s trots” firmly in the spotlight — but exercise-induced diarrhoea, urgency and even faecal incontinence can happen to athletes at every level. During hard endurance exercise, blood is diverted away from the gut, repetitive impact can stimulate bowel activity, and heat, dehydration and pre-race nutrition can push the digestive system beyond its comfort zone. The result can be a sudden and sometimes very urgent need to go — with surprisingly little warning. So why does it happen, and can you prevent it? Here’s the real physiology behind one of endurance sport’s most awkward problems.

PRP for Knee Osteoarthritis: How Many Injections Do You Need, and How Long Does Relief Last?

If you're considering PRP for knee osteoarthritis, two of the biggest questions are how many injections are needed and how long the results may last. Recent research provides useful insight into both, with many clinical trials using a short course of 2–3 injections rather than a single treatment. Our latest evidence update looks at the durability of PRP, how platelet concentration may influence the length of benefit, and when a repeat course may be considered for patients who respond well.

Rotator Cuff Tendinopathy and PRP: Modest but Durable Benefit

Rotator cuff tendinopathy and partial-thickness tears are common causes of persistent shoulder pain, particularly when symptoms don't settle with rehabilitation alone. Research into PRP is growing, with recent trials suggesting its benefits may be modest but more durable over time compared with corticosteroid injections. Our latest evidence update explores the shoulder-specific research, including partial-thickness tears, injection technique and why precise targeting and a structured strengthening program remain important when considering PRP.